Literature DB >> 22561553

Study of the genetic variability in a Parkinson's Disease gene: EIF4G1.

Arianna Tucci1, Gavin Charlesworth, Una-Marie Sheerin, Vincent Plagnol, Nicholas W Wood, John Hardy.   

Abstract

Chartier-Harlin and colleagues [2] recently reported mutations in the eukaryotic translation initiation factor 4-gamma (EIF4G1) gene in families with parkinsonism. Large-scale screening found two mutations (p.R1205H and p.A502V) only in affected individuals, although their relative frequency was very low. The aim of this study was to investigate EIF4G1 parkinsonism-related variants in two separate cohorts and study coding variability across the gene. We first screened a series of familial Parkinson's Disease (PD) patients in an attempt to confirm previous results by showing segregation. Then, to determine the extent of coding variation in the gene, we first screened a cohort of sub-Saharan African individuals from the Centre d'Etude du Polymorphisme Humain - Human Genome Diversity Cell Line Panel (HGDP) [1] and then analyzed data from 5350 individuals National Heart, Lung, and Blood Institute (NHLBI) exome sequencing project. We failed to identify any PD-related mutations in the familial samples. Conversely we found the p.A502V variant in the NHLBI population. We observed a high number of coding polymorphism in the exons where the two PD variants have been previously reported. We conclude that either EIF4G1 variants are an extremely rare cause of familial PD in Caucasian cohorts, or that A502V is in fact a rare benign variant not involved in PD aetiology. Our data also suggests that the protein can tolerate some extent of variability particularly at this point of the gene.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22561553      PMCID: PMC3769807          DOI: 10.1016/j.neulet.2012.04.033

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


Recently, a new gene (EIF4G1) has been identified in one family with autosomal dominant late-onset Parkinson's Disease [2]. Linkage was ascribed to a region at chromosome 3q26–28 containing approximately 159 genes. Sequence analysis found only one novel coding variant (p.R1205H in the EIF4G1 gene) which segregated with disease, which was absent in 4050 controls and which was evolutionary conserved in mammals. Screening a cohort of about 4800 PD cases (familial and sporadic) identified nine additional patients of the p.R1205H mutation. Further molecular analysis of the EIF4G1 gene in a large case–control cohort (4500 cases and 3800 controls) identified another novel missense mutation (p.A502V) in three PD individuals, which was not found in controls. These data indicate that these variants are extremely rare in the PD population (0.2% for p.R1205H and 0.06% for p.A502V). Assignment of pathogenicity can be difficult when variants are very rare. With this background, we screened 150 familial PD cases from our UK familial Parkinson's Disease series, in which we have previously identified LRRK2, VPS35 and SNCA mutations [5,7] in order to determine whether we could provide further that this gene is indeed a PD-related locus. We also assessed these coding positions in a set of African samples (Table 1) from the Human Diversity series – a standard panel of African samples [1], as African samples have the greatest diversity and offer a rapid route to the identification of benign polymorphisms [4]. Briefly, exon 8 and exon 22 of the EIF4G1 gene (NM_182917.3) were PCR amplified and sequenced in the two cohorts for a total of 114 African samples and 150 familial PD cases.
Table 1

Number of African samples studied per population and geographic regions.

No. of samplesPopulationGeographic origin
35Biaka PygmyCentral African Republic
15Mbuti PygmyDemocratic Republic of Congo
12Bantu N.E.Kenya
7SanNamibia
26YorubaNigeria
24MandenkaSenegal
8Bantu S.E. PediSouth Africa
To obtain a more exhaustive description of the pattern of variability in that gene we also extracted genotype data from the NHLBI exome sequencing project (Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA (http://evs.gs.washington.edu/EVS/) [January 2011], which includes exome data for 3500 American individuals of European descent and 1850 African American. Frequencies were computed using VCFtools. We used the software ANNOVAR [8] to annotate the function of the variants. We failed to identify any mutation previously reported to be associated with PD our familial cohort, but we identified one coding change (P486S) in two PD individuals. The P486S variant is reported in dbSNP (rs112545306). Interestingly it has been observed in African-Americans (http://snp.gs.washington.edu/EVS), with a frequency of 0.15%. We identified six non-synonymous changes in exon 8 and in exon 22 in the African individuals. Of these, one is a novel change (P382L), the others are variants recently reported in dbSNP and found mainly in African populations (http://snp.gs.washington.edu/EVS). To predict the impact on protein function of these non-synonymous variants, we performed an in silico analysis using the software PolyPhen and SIFT [6] and all were predicted to be benign (Table 2).
Table 2

EIF4G1 coding variant detected in the African cohort (NM_182917.4).

Nucleotide changeProtein changeSNP accession numberFrequencyPopulationEffect (SIFT)
c.870G>AM290Irs1449471450.01San, Bantu SETolerated
c.913C>TR305Crs1165088850.01YourubaTolerated
c.932A>GY311Crs168586320.03Bantu SW, Bantu NE, Yoruba, MandenkaTolerated
c.1145C>TP382LNA0.004SanTolerated
c.1429G>AE477Krs1452287180.004MandenkaTolerated
c.3918G>AR1216Hrs340861090.004Biaka PygmyTolerated
Analysis of the NHLBI samples allowed us to detect the A502V variant in two European-American individuals (frequency of 0.02%). We identified 95 nonsynonymous SNP over 32 exons in total (NM_182917.3). Of note, 36 of them are located in exon 8 and exon 22 (Table 3). To investigate coding variability across the EIF4G1 gene we extracted the data from the NHLBI dataset and computed the average number of pairwise amino acid differences between two randomly selected European-American haplotypes from the NHLBI dataset (Methods). On average two such EIF4G1 sequences diverge by 0.45 aminoacids. 82% of this variability (0.37 amino-acid differences) locates to exon 8, where the A502V lies. 9.8% of this variability locates to exon 22 (0.098 amino-acid differences). Combined with the identification of six coding variants in exons 8 and 22 in African samples, these data are consistent with a more limited selective pressure and a higher sequence variability in this region of the EIF4G1 protein.
Table 3

EIF4G1 coding variants present in NHLBI Exome Sequencing Project (NM_182917.4). EA = European American population. AA = African American population.

Nucleotide changeProtein changeSNP accession numberFrequency (EA)Frequency (AA)Exon
c.C71TP24L0.00014202
c.C167GA56G0.00014203
c.C211TP71Srs1138109470.00028503
c.282C>GI94M00.0002683
c.451C>GV151L0.00014305
c.481A>GA161Trs133191490.9967220.9994655
C.602G>AR201Hrs348383050.00042706
C.608C>TA203V0.00014206
C.704G>AR235Qrs1445439530.0001420.0002688
C.731G>AR244Qrs1478555660.00014208
C.779C>TS260L0.00014208
c.821C>TP274Lrs13962633800.0002688
c.870G>AM290Irs14494714500.0013388
c.913C>TR305Crs11650888500.003218
c.914G>AR205Hrs1511511940.0001420.0002688
c.926A>GE309G0.00014208
c.932A>GY311Crs168586320.0004270.0596588
c.1001A>CP334Q0.00028508
c.1013C>TS338Frs13902180600.0002688
c.1036C>AQ346K00.0002688
c.1054G>TA352S0.00014208
c.1063A>GT355A00.0002688
c.1064C>TT355I00.0002688
c.1142C>GA381Grs1420956940.00014208
c.1256G>TS419Irs13820726900.0005358
c.1294A>GM432Vrs21784030.7595440.9435538
c.1298C>TA433Vrs1459989210.00014208
c.1309A>GI437Vrs14422202800.0002688
c.1316C>AS439Yrs1487091740.00014208
c.1331C>TT444Mrs14301457000.0002688
c.1352C>AP451Qrs1474199960.00014208
c.1429G>AE477Krs14522871800.0002688
c.1456C>TP486Srs1125453060.000570.0008038
c.1505C>TA502Vrs1112909360.00028508
c.1610C>TA537V00.00026810
c.1648G>CA550Prs1119249940.0019940.00053510
c.1679G>AG560Drs1496858750.000142010
c.1696C>TR566Crs1455214790.0001420.00026810
c.1700C>AP567Hrs14021215000.00026810
c.1754A>CE585A00.00026810
c.1801T>CW601Rrs14524731800.00026811
c.1831C>TR611C00.00026811
c.1980A>GI660M0.000142012
c.1982A>GN661Srs1457805340.000142012
c.2096G>CG699A0.000142013
c.2114C>GS705Crs1410544520.000142013
c.2152G>CA718Prs1113967650.0015670.00026813
c.2225C>TT742Mrs14767859300.00401313
c.2276A>GQ759R0.000142014
c.2278G>CD760Hrs1429470140.000142014
c.2386A>GK796E00.00026814
c.2419A>GI807Vrs622874990.000427014
c.2488A>TT830Srs1115001850.000285015
c.2612A>CE871A0.000142015
c.2671A>GI891V00.00026816
c.2882A>GN961Srs19188868800.00026817
c.3187C>TR1063C0.000142019
c.3221C>TT1074Irs1464331450.000142019
c.3343C>TR1115Crs15005420200.00026821
c.3428A>GQ1143Rrs14541466000.00026821
c.3482G>AR1161Hrs1391356830.000427022
c.3511C>TR1171Crs14168420200.00026822
c.3529C>TR1177C00.00026822
c.3580C>TR1194W0.000142022
c.3584G>AS1195N0.000142022
c.3592C>TR1198Wrs11338824200.00026822
c.3617G>AR1206Hrs1121764500.000285022
c.3649C>TR1207C0.000143022
c.3650G>AR1217Hrs3408610900.01043322
c.3652G>AG1217Rrs13827011700.00026822
c.3686C>TP1299L00.00026823
c.3688C>GP1230Ars356299490.0058420.00160623
c.3701T>CL1234Prs22305700.0219370.08025723
c.3743A>GK1248R0.000142023
c.3773A>GN1258Srs7305376600.00187323
c.3935C>TS1312F00.00026824
c.3937A>GT1313Ars1445703320.0001420.00080324
c.3988A>GM1330Vrs1128098280.000285025
c.4067T>CM1356Trs1440591510.000855025
c.4068G>CM1356Irs1459759050.000285025
c.4081A>GR1361Grs13979372100.00026825
c.4106C>TP1369Lrs14206442800.00080326
c.4184C>TT1395Mrs11244172100.00026827
c.4201G>AG1401Rrs1498214180.0001420.00080327
c.4229A>CE1410Ars14177679000.00026827
c.4259A>GE1420G00.00026827
c.4292C>TS1431L0.0001420.00026828
c.4300C>TP1434Srs1476960970.000142028
c.4379G>AR1460Q0.000142028
c.4399G>AA1467Trs1482707240.000142029
c.4433C>TT1478Mrs1413794720.000142029
c.4454C>TT1485M0.000142029
c.4486A>TT1496S00.00026829
c.4712C>TA1571Vrs1444625940.000142031
c.4772G>AR1591H0.000142031
These data, combined with the presence of the A502V in the NHLBI population with 0.02% frequency and our failure to identify any PD mutation carrier in our familial cohort, are consistent with the interpretation that either EIF4G1 variants are an extremely rare cause of familial PD in Caucasian cohorts, or that A502V is in fact a rare benign variant not involved in PD aetiology.

Role of the funding source

This study was supported by Parkinson's Disease Society (AT) and by the Medical Research Council and Wellcome Trust Disease Centre (grant WT089698/Z/09/Z). DNA extraction work was undertaken at University College London Hospitals, University College London, who received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding.

Disclosure statement

Arianna Tucci, Gavin Charlesworth, Una-Marie Sheerin, Vincent Plagnol, Nick Wood, John Hardy report no disclosures.
  7 in total

1.  A human genome diversity cell line panel.

Authors:  Howard M Cann; Claudia de Toma; Lucien Cazes; Marie-Fernande Legrand; Valerie Morel; Laurence Piouffre; Julia Bodmer; Walter F Bodmer; Batsheva Bonne-Tamir; Anne Cambon-Thomsen; Zhu Chen; J Chu; Carlo Carcassi; Licinio Contu; Ruofu Du; Laurent Excoffier; G B Ferrara; Jonathan S Friedlaender; Helena Groot; David Gurwitz; Trefor Jenkins; Rene J Herrera; Xiaoyi Huang; Judith Kidd; Kenneth K Kidd; Andre Langaney; Alice A Lin; S Qasim Mehdi; Peter Parham; Alberto Piazza; Maria Pia Pistillo; Yaping Qian; Qunfang Shu; Jiujin Xu; S Zhu; James L Weber; Henry T Greely; Marcus W Feldman; Gilles Thomas; Jean Dausset; L Luca Cavalli-Sforza
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

2.  Translation initiator EIF4G1 mutations in familial Parkinson disease.

Authors:  Marie-Christine Chartier-Harlin; Justus C Dachsel; Carles Vilariño-Güell; Sarah J Lincoln; Frédéric Leprêtre; Mary M Hulihan; Jennifer Kachergus; Austen J Milnerwood; Lucia Tapia; Mee-Sook Song; Emilie Le Rhun; Eugénie Mutez; Lydie Larvor; Aurélie Duflot; Christel Vanbesien-Mailliot; Alexandre Kreisler; Owen A Ross; Kenya Nishioka; Alexandra I Soto-Ortolaza; Stephanie A Cobb; Heather L Melrose; Bahareh Behrouz; Brett H Keeling; Justin A Bacon; Emna Hentati; Lindsey Williams; Akiko Yanagiya; Nahum Sonenberg; Paul J Lockhart; Abba C Zubair; Ryan J Uitti; Jan O Aasly; Anna Krygowska-Wajs; Grzegorz Opala; Zbigniew K Wszolek; Roberta Frigerio; Demetrius M Maraganore; David Gosal; Tim Lynch; Michael Hutchinson; Anna Rita Bentivoglio; Enza Maria Valente; William C Nichols; Nathan Pankratz; Tatiana Foroud; Rachel A Gibson; Faycal Hentati; Dennis W Dickson; Alain Destée; Matthew J Farrer
Journal:  Am J Hum Genet       Date:  2011-09-09       Impact factor: 11.025

3.  A thorough assessment of benign genetic variability in GRN and MAPT.

Authors:  Rita J Guerreiro; Nicole Washecka; John Hardy; Andrew Singleton
Journal:  Hum Mutat       Date:  2010-02       Impact factor: 4.878

4.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

5.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

6.  Screening for VPS35 mutations in Parkinson's disease.

Authors:  Una-Marie Sheerin; Gavin Charlesworth; Jose Bras; Rita Guerreiro; Kailash Bhatia; Thomas Foltynie; Patricia Limousin; Laura Silveira-Moriyama; Andrew Lees; Nicholas Wood
Journal:  Neurobiol Aging       Date:  2011-12-07       Impact factor: 4.673

7.  Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data.

Authors:  Naheed L Khan; Shushant Jain; John M Lynch; Nicola Pavese; Patrick Abou-Sleiman; Janice L Holton; Daniel G Healy; William P Gilks; Mary G Sweeney; Milan Ganguly; Vaneesha Gibbons; Sonia Gandhi; Jenny Vaughan; Louise H Eunson; Regina Katzenschlager; Juliet Gayton; Graham Lennox; Tamas Revesz; David Nicholl; Kailash P Bhatia; Niall Quinn; David Brooks; Andrew J Lees; Mary B Davis; Paola Piccini; Andrew B Singleton; Nicholas W Wood
Journal:  Brain       Date:  2005-11-04       Impact factor: 13.501

  7 in total
  15 in total

Review 1.  Parkinson's disease in Nigeria: A review of published studies and recommendations for future research.

Authors:  Oluwafemi G Oluwole; Helena Kuivaniemi; Jonathan A Carr; Owen A Ross; Matthew O B Olaogun; Soraya Bardien; Morenikeji A Komolafe
Journal:  Parkinsonism Relat Disord       Date:  2018-12-08       Impact factor: 4.891

2.  Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia.

Authors:  Shinsuke Fujioka; Christina Sundal; Audrey J Strongosky; Monica Case Castanedes; Rosa Rademakers; Owen A Ross; Carles Vilariño-Güell; Matthew J Farrer; Zbigniew K Wszolek; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2012-11-04       Impact factor: 17.088

Review 3.  Whole-genome and whole-exome sequencing in neurological diseases.

Authors:  Jia-Nee Foo; Jian-Jun Liu; Eng-King Tan
Journal:  Nat Rev Neurol       Date:  2012-07-31       Impact factor: 42.937

4.  Variants in eukaryotic translation initiation factor 4G1 in sporadic Parkinson's disease.

Authors:  Eva C Schulte; Brit Mollenhauer; Alexander Zimprich; Benjamin Bereznai; Peter Lichtner; Dietrich Haubenberger; Walter Pirker; Thomas Brücke; Maria J Molnar; Annette Peters; Christian Gieger; Claudia Trenkwalder; Juliane Winkelmann
Journal:  Neurogenetics       Date:  2012-06-16       Impact factor: 2.660

5.  EIF4G1 mutations do not cause Parkinson's disease.

Authors:  Noah Nichols; Jose M Bras; Dena G Hernandez; Iris E Jansen; Suzanne Lesage; Steven Lubbe; Andrew B Singleton
Journal:  Neurobiol Aging       Date:  2015-05-09       Impact factor: 4.673

6.  Whole exome sequencing of rare variants in EIF4G1 and VPS35 in Parkinson disease.

Authors:  Karen Nuytemans; Guney Bademci; Vanessa Inchausti; Amy Dressen; Daniel D Kinnamon; Arpit Mehta; Liyong Wang; Stephan Züchner; Gary W Beecham; Eden R Martin; William K Scott; Jeffery M Vance
Journal:  Neurology       Date:  2013-02-13       Impact factor: 9.910

7.  EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population.

Authors:  Kenya Nishioka; Manabu Funayama; Carles Vilariño-Güell; Kotaro Ogaki; Yuanzhe Li; Ryogen Sasaki; Yasumasa Kokubo; Shigeki Kuzuhara; Jennifer M Kachergus; Stephanie A Cobb; Hirohide Takahashi; Yoshikuni Mizuno; Matthew J Farrer; Owen A Ross; Nobutaka Hattori
Journal:  Parkinsonism Relat Disord       Date:  2014-03-18       Impact factor: 4.891

Review 8.  Advances in the Genetics of Parkinson's Disease: A Guide for the Clinician.

Authors:  Una-Marie Sheerin; Henry Houlden; Nicholas W Wood
Journal:  Mov Disord Clin Pract       Date:  2014-04-10

9.  Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

Authors:  Prabhjyot Saini; Uladzislau Rudakou; Eric Yu; Jennifer A Ruskey; Farnaz Asayesh; Sandra B Laurent; Dan Spiegelman; Stanley Fahn; Cheryl Waters; Oury Monchi; Yves Dauvilliers; Nicolas Dupré; Lior Greenbaum; Sharon Hassin-Baer; Alberto J Espay; Guy A Rouleau; Roy N Alcalay; Edward A Fon; Ronald B Postuma; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2020-10-31       Impact factor: 4.673

Review 10.  Recent advances in Parkinson’s disease genetics.

Authors:  Steven Lubbe; Huw R Morris
Journal:  J Neurol       Date:  2014-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.